Xtl Biopharmaceuticals (XTLB) Other Operating Expenses (2009 - 2013)

Xtl Biopharmaceuticals (XTLB) has reported Other Operating Expenses for 4 consecutive years, with $3000.0 the latest figure, recorded in Q4 2013.

• Quarterly Other Operating Expenses fell 57.14% year-over-year to $3000.0 in Q4 2013, while the trailing twelve-month figure through Sep 2014 was $3000.0 (down 99.72% YoY) and the FY2015 annual result came in at -$10000.0, down 107.04% from the prior year.
• Other Operating Expenses retreated to $3000.0 in Q4 2013 per XTLB's latest filing, from $1.0 million in the prior quarter.
• Over the last five years, Other Operating Expenses for XTLB reached as high as $1.0 million in Q3 2013 and fell as low as -$783000.0 in Q4 2011.
• A 4-year average of $129090.9 and a median of $7000.0 in 2012 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2012 — Other Operating Expenses surged 100.89% — and 2013, when it slumped 99.12%.
• Year by year, Other Operating Expenses stood at -$5000.0 in 2009, then plunged by 15560.0% to -$783000.0 in 2011, then soared by 100.89% to $7000.0 in 2012, then slumped by 57.14% to $3000.0 in 2013.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $3000.0, $1.0 million, and $3000.0 for Q4 2013, Q3 2013, and Q2 2013 respectively.